Abstract
Biotechnology has been used for a long period of time in the most diverse scientific areas, making its journey in close contact with pharmaceutical sciences. Among the several products manufactured in biotechnological industry, peptides and proteins are in the front-line for the treatment of several diseases due to their selectivity, effective action and few side effects. However, orally administration route is not feasible for peptide and protein drugs due to the several physical and chemical barriers along the gastrointestinal tract and, consequently, are delivery by parental routes. Between several strategies, it is believed that delivery systems can render the oral route viable, increasing the convenience and compliance of patients and enhancing drugs therapeutic effect. Recently, more specific strategies have been explored to better direct the delivery systems, achieved by their functionalization with ligands that specifically bind to membrane transporters and receptors existing along the gastrointestinal way. Despite the promising results obtained with functionalized nanoparticles, the oral delivery of peptides/proteins is still limited and a lot of research is required to successfully introduce nanoparticles in the clinical field.
Keywords: Functionalized nanoparticles, gastrointestinal membrane receptors, gastrointestinal membrane transporters, oral delivery.
Current Pharmaceutical Biotechnology
Title:Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
Volume: 15 Issue: 7
Author(s): Carla Pereira, Francisca Araujo, Pedro L. Granja, Helder A. Santos and Bruno Sarmento
Affiliation:
Keywords: Functionalized nanoparticles, gastrointestinal membrane receptors, gastrointestinal membrane transporters, oral delivery.
Abstract: Biotechnology has been used for a long period of time in the most diverse scientific areas, making its journey in close contact with pharmaceutical sciences. Among the several products manufactured in biotechnological industry, peptides and proteins are in the front-line for the treatment of several diseases due to their selectivity, effective action and few side effects. However, orally administration route is not feasible for peptide and protein drugs due to the several physical and chemical barriers along the gastrointestinal tract and, consequently, are delivery by parental routes. Between several strategies, it is believed that delivery systems can render the oral route viable, increasing the convenience and compliance of patients and enhancing drugs therapeutic effect. Recently, more specific strategies have been explored to better direct the delivery systems, achieved by their functionalization with ligands that specifically bind to membrane transporters and receptors existing along the gastrointestinal way. Despite the promising results obtained with functionalized nanoparticles, the oral delivery of peptides/proteins is still limited and a lot of research is required to successfully introduce nanoparticles in the clinical field.
Export Options
About this article
Cite this article as:
Pereira Carla, Araujo Francisca, Granja L. Pedro, Santos A. Helder and Sarmento Bruno, Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems, Current Pharmaceutical Biotechnology 2014; 15 (7) . https://dx.doi.org/10.2174/1389201015666140915152330
DOI https://dx.doi.org/10.2174/1389201015666140915152330 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anthocyanins: Plant Pigments, Food Ingredients or Therapeutic Agents for the CNS? A Mini-Review Focused on Clinical Trials
Current Pharmaceutical Design Occurrence and Biological Activities of Eremophilane-type Sesquiterpenes
Mini-Reviews in Medicinal Chemistry UGT1A1 Gene Polymorphisms and the Toxicities of FOLFIRI in Chinese Han Patients with Gastrointestinal Cancer
Anti-Cancer Agents in Medicinal Chemistry Gels and Jellies as a Dosage Form for Dysphagia Patients: A Review
Current Drug Therapy Biophysical Screening for Identifying Pharmacological Chaperones and Inhibitors Against Conformational and Infectious Diseases
Current Drug Targets Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics
Current Drug Targets Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
Current Pharmaceutical Design Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer
Current Topics in Medicinal Chemistry Multi-target Activities of Selected Alkaloids and Terpenoids
Mini-Reviews in Organic Chemistry Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease
Current Alzheimer Research Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions
Current Medicinal Chemistry Editorial: [Hot Topic: Nanotechnology and Patents in Agriculture, Food Technology, Nutrition and Medicine - Advantages and Risks]
Recent Patents on Food, Nutrition & Agriculture Current Evidence from Phase III Clinical Trials of Selenium Supplementation in Critically Ill Patients: Why Should We Bother?
Mini-Reviews in Medicinal Chemistry The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Discovery and Protein Tyrosine Phosphatases
Current Medicinal Chemistry 99mTc-HYNIC-D4 Peptide: A New Small Radiolabeled Peptide for Non Small Cell Lung Tumor Targeting
Anti-Cancer Agents in Medicinal Chemistry An Overview on the Role of miR-451 in Lung Cancer: Diagnosis, Therapy, and Prognosis
MicroRNA Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Current Vascular Pharmacology Genetic Chemoprotection with Mutant O6-Alkylguanine-DNA-Alkyltransferases
Current Gene Therapy Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents